[{"address1": "5 Science Park", "address2": "395 Winchester Avenue", "city": "New Haven", "state": "CT", "zip": "06511", "country": "United States", "phone": "203 535 1456", "website": "https://www.arvinas.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.", "fullTimeEmployees": 430, "companyOfficers": [{"maxAge": 1, "name": "Dr. John G. Houston Ph.D.", "age": 63, "title": "Chairperson, CEO & President", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1144497, "exercisedValue": 0, "unexercisedValue": 12278804}, {"maxAge": 1, "name": "Dr. Ian  Taylor Ph.D.", "age": 62, "title": "President of Research & Development and Chairman of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 732256, "exercisedValue": 0, "unexercisedValue": 1344633}, {"maxAge": 1, "name": "Mr. Andrew R. Saik", "age": 55, "title": "CFO & Treasurer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Loomis M.B.A.", "age": 50, "title": "VP & Chief Accounting Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela M. Cacace Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jared M. Freedberg J.D.", "age": 55, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Weiss", "age": 54, "title": "Senior VP & Chief Human Resources Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Randy  Teel Ph.D.", "age": 44, "title": "Chief Business Officer", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Sinclair", "title": "Senior Vice President of Corporate Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  McInulty", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.06, "open": 17.97, "dayLow": 17.76, "dayHigh": 18.76, "regularMarketPreviousClose": 18.06, "regularMarketOpen": 17.97, "regularMarketDayLow": 17.76, "regularMarketDayHigh": 18.76, "payoutRatio": 0.0, "beta": 1.962, "forwardPE": -3.9227471, "volume": 1922371, "regularMarketVolume": 1922371, "averageVolume": 1100470, "averageVolume10days": 1410910, "averageDailyVolume10Day": 1410910, "bid": 18.13, "ask": 23.0, "bidSize": 3, "askSize": 2, "marketCap": 1257150464, "fiftyTwoWeekLow": 15.53, "fiftyTwoWeekHigh": 47.24, "priceToSalesTrailing12Months": 4.772781, "fiftyDayAverage": 18.2082, "twoHundredDayAverage": 24.1588, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 227449728, "profitMargins": -0.75513, "floatShares": 53692260, "sharesOutstanding": 68771904, "sharesShort": 11540484, "sharesShortPriorMonth": 9763059, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.16780001, "heldPercentInsiders": 0.07618, "heldPercentInstitutions": 1.10525, "shortRatio": 11.9, "shortPercentOfFloat": 0.1708, "impliedSharesOutstanding": 68771904, "bookValue": 8.164, "priceToBook": 2.2390988, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -198900000, "trailingEps": -2.77, "forwardEps": -4.66, "enterpriseToRevenue": 0.864, "enterpriseToEbitda": -0.926, "52WeekChange": -0.59824175, "SandP52WeekChange": 0.12744582, "quoteType": "EQUITY", "currentPrice": 18.28, "targetHighPrice": 110.0, "targetLowPrice": 32.0, "targetMeanPrice": 62.42105, "targetMedianPrice": 60.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 19, "totalCash": 1039400000, "totalCashPerShare": 15.114, "ebitda": -245600000, "totalDebt": 9700000, "quickRatio": 4.583, "currentRatio": 4.644, "totalRevenue": 263400000, "debtToEquity": 1.727, "revenuePerShare": 3.663, "returnOnAssets": -0.13053, "returnOnEquity": -0.32561, "grossProfits": 263400000, "freeCashflow": -99275000, "operatingCashflow": -259300000, "grossMargins": 1.0, "ebitdaMargins": -0.93241996, "operatingMargins": -0.98310995, "financialCurrency": "USD", "symbol": "ARVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Arvinas, Inc.", "longName": "Arvinas, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": 1.2181685, "regularMarketPrice": 18.28, "corporateActions": [], "postMarketTime": 1741395311, "regularMarketTime": 1741381201, "exchange": "NMS", "messageBoardId": "finmb_243040896", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1538055000000, "postMarketChangePercent": 3.93873, "postMarketPrice": 19.0, "postMarketChange": 0.719999, "regularMarketChange": 0.22000122, "regularMarketDayRange": "17.76 - 18.76", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1100470, "fiftyTwoWeekLowChange": 2.750001, "fiftyTwoWeekLowChangePercent": 0.1770767, "fiftyTwoWeekRange": "15.53 - 47.24", "fiftyTwoWeekHighChange": -28.960001, "fiftyTwoWeekHighChangePercent": -0.6130398, "fiftyTwoWeekChangePercent": -59.824173, "earningsTimestamp": 1739275204, "earningsTimestampStart": 1746102600, "earningsTimestampEnd": 1746448200, "earningsCallTimestampStart": 1739278800, "earningsCallTimestampEnd": 1739278800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.77, "epsForward": -4.66, "epsCurrentYear": -3.84327, "priceEpsCurrentYear": -4.7563663, "fiftyDayAverageChange": 0.07180023, "fiftyDayAverageChangePercent": 0.003943291, "twoHundredDayAverageChange": -5.8787994, "twoHundredDayAverageChangePercent": -0.24333988, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Arvinas", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]